Looking at the hazard ratio of each subgroup of luminal B-like tumors, patients with low PR (subgroup 3) had a higher risk of BC mortality than those with high Ki67 (subgroup 2) (HR= 3.43 and HR= 2.57, respectively). Here, MKI67 is linked to breast cancer.